Pharmaceuticals

MD Groups Respond to Study Linking GLP-1 Treatment to NAION

The American Academy of Ophthalmology and North American Neuro-Ophthalmology Society stress that more research is needed to determine whether the association is causal.

07/11/2024

Fluoroquinolone Use Not Linked to Increased Uveitis, Retinal Detachment Risk

Although an association with this antibiotic treatment cannot be completely ruled out, any absolute effect would be small.

05/31/2024

Have You Kept Up with the Recent 'New Drug' Deluge?

Optometrists have access to many new meds right now, with a flood of more on the way. Here’s a comprehensive review of what’s out now and what’s in the pipeline.

03/15/2024

Safe and Savvy Prescribing of Oral Pharmaceuticals

Two experts share their best “dos and don'ts” to help you confidently handle the most common scenarios across several different categories of medications.

03/15/2024

The Wild and Woolly World of Anti-VEGF in 2023

A once-simple treatment protocol has gotten more sophisticated—and complicated—by novel drug compounds, varied dosing regimens and sustained-release delivery methods. Here’s the current state of affairs.

09/15/2023

Innovations, Part Two

These products are making an impact in the eyecare world.

05/15/2023

Statin Use, Certain Ethnicities Linked to Late-Onset AMD

On the flip side, female sex, obesity and fluoxetine use were found to be associated with earlier development.

03/17/2023

Restrictive Drug Formularies: How to Beat the Odds

When insurers stack the deck against you and your patients, you can still play a winning hand.

03/15/2023

Presbyopia Drugs: A Drop in the Bucket?

With one med available and others coming soon, patients have more options than ever for near vision correction. Do they offer enough to make a difference in a well-established market?

03/15/2023